SEC Filing 8-K: BIODELIVERY SCIENCES INTERNATIONAL INC
February 6, 2018 4:32pm EST
Source: SEC (Index ) via Sqoop
- § Entry into a Material Definitive Agreement;
- § Departure/Appointment/Compensation of Officers/Directors;
- § Other Events;
- § Financial Statements and Exhibits;
10.1 Form of Indemnification Agreement
10.2 Consulting Agreement, dated February 2, 2018, between the Company and Sirgo.
99.1 Press release, dated February 6, 2018, announcing the Company s entry into a settlement agreement with Teva.